VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WTW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WTWWillis Towers Watson Public Limited Company
$287.66$27.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWTWQuarterly Financials

Willis Towers Watson Public Limited Company (WTW) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Willis Towers Watson Public Limited Company (WTW) quarterly income statement — complete revenue, gross profit & net income history

WTW Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue2.41B2.94B2.29B2.26B2.22B3.04B2.29B2.27B2.34B2.91B2.17B2.16B2.24B2.72B1.95B2.03B2.16B2.71B1.97B2.09B
Revenue Growth %8.5%-3.26%-0.04%-0.18%-5.04%4.15%5.68%4.91%4.32%7.05%10.91%6.3%3.89%0.59%-1.01%-2.87%-3.05%-2.1%4.01%-1.04%
Medical Costs & Claims1.82B1.44B1.41B1.45B1.32B1.37B1.4B1.4B1.34B533M396M1.35B1.31B1.26B1.23B1.26B1.32B1.26B1.25B1.32B
Medical Cost Ratio %75.41%49.01%61.76%64.09%59.56%45.04%60.99%61.68%57.33%18.29%18.28%62.39%58.51%46.4%62.72%61.99%61.02%46.64%63.61%62.98%
Gross Profit593M1.5B875M812M899M1.67B893M868M999M2.38B1.77B812M931M1.46B728M772M842M1.44B718M774M
Gross Margin %24.59%50.99%38.24%35.91%40.44%54.96%39.01%38.32%42.67%81.71%81.72%37.61%41.49%53.6%37.28%38.01%38.98%53.36%36.39%37.02%
Gross Profit Growth %-34.04%-10.25%-2.02%-6.45%-10.01%-29.95%-49.55%6.9%7.3%63.19%143.13%5.18%10.57%1.04%1.39%-0.26%4.08%7.36%8.95%3.2%
Operating Expenses145M481M457M444M467M767M1.66B656M719M1.6B1.61B670M646M751M574M635M663M754M-413M604M
OpEx / Revenue %6.01%16.38%19.97%19.64%21.01%25.27%72.48%28.96%30.71%54.98%74.38%31.03%28.79%27.59%29.39%31.27%30.69%27.86%-20.93%28.89%
Depreciation & Amortization56M109M103M106M102M104M116M117M119M118M122M134M131M137M131M148M151M153M154M170M
Combined Ratio %81.43%65.4%81.73%83.72%80.57%70.31%133.46%90.64%88.04%73.27%92.66%93.42%87.3%73.99%92.11%93.25%91.71%74.5%42.68%91.87%
Operating Income448M1.02B418M368M432M901M-766M212M280M779M159M142M285M708M154M137M179M690M1.13B170M
Operating Margin %18.57%34.6%18.27%16.28%19.43%29.69%-33.46%9.36%11.96%26.73%7.34%6.58%12.7%26.01%7.89%6.75%8.29%25.5%57.32%8.13%
Operating Income Growth %3.7%12.76%154.57%73.58%54.29%15.66%-581.76%49.3%-1.75%10.03%3.25%3.65%59.22%2.61%-86.38%-19.41%-15.17%17.55%1613.64%4.29%
EBITDA504M1.13B521M474M534M1B-650M329M399M897M281M276M416M845M285M285M330M843M1.28B340M
EBITDA Margin %20.9%38.32%22.77%20.96%24.02%33.11%-28.4%14.53%17.04%30.78%12.97%12.78%18.54%31.04%14.59%14.03%15.28%31.15%65.13%16.26%
Interest Expense77M66M65M64M65M66M65M68M64M63M61M57M54M54M54M51M49M50M50M52M
Non-Operating Income0-19M-37M-9M64M-853M-1.12B-23M-26M-23M-66M-35M-25M-83M-85M-93M-27M-84M-105M-74M
Pretax Income376M933M383M311M304M1.69B-1.99B168M242M739M164M120M256M737M185M179M157M724M1.19B192M
Pretax Margin %15.59%31.78%16.74%13.75%13.68%55.62%-87.11%7.42%10.34%25.36%7.57%5.56%11.41%27.08%9.47%8.81%7.27%26.76%60.11%9.18%
Income Tax70M197M77M-21M65M440M-322M26M48M116M25M24M50M131M1M19M43M150M267M75M
Effective Tax Rate %18.62%21.11%20.1%-6.75%21.38%26.07%16.15%15.48%19.83%15.7%15.24%20%19.53%17.77%0.54%10.61%27.39%20.72%22.51%39.06%
Net Income297M735M304M331M235M1.25B-1.68B141M190M622M136M94M203M588M190M109M122M2.4B903M184M
Net Margin %12.31%25.03%13.29%14.64%10.57%41.05%-73.18%6.23%8.12%21.35%6.28%4.35%9.05%21.6%9.73%5.37%5.65%88.77%45.77%8.8%
Net Income Growth %26.38%-41.01%118.15%134.75%23.68%100.32%-1331.62%50%-6.4%5.78%-28.42%-13.76%66.39%-75.52%-78.96%-40.76%-83.36%404.62%646.28%95.74%
EPS (Diluted)3.107.623.113.312.3312.22-16.421.361.835.981.290.881.885.401.711.431.0319.196.991.41
EPS Growth %33.05%-37.64%118.94%143.38%27.32%104.35%-1372.87%54.55%-2.66%10.74%-24.56%-38.46%82.52%-71.86%-75.54%1.42%-81.71%424.32%651.61%95.83%
EPS (Basic)3.127.663.103.342.3512.34-16.421.371.846.021.300.881.905.421.731.431.0319.237.011.42
Diluted Shares Outstanding95.81M97M100M100M101M102M102M103M104M104M105M107M108M109M111M112M118M125M129M130M